Search results
Results from the WOW.Com Content Network
Donanemab, sold under the brand name Kisunla, is a monoclonal antibody used for the treatment of Alzheimer's disease. [1] [2] Donanemab was developed by Eli Lilly and Company. [3] [4] The most common side effects include amyloid-related imaging abnormalities and headache. [2] Donanemab was approved for medical use in the United States in July 2024.
Donepezil is a centrally acting reversible acetylcholinesterase inhibitor and structurally unrelated to other anticholinesterase agents. [8] [5] Common side effects include nausea, trouble sleeping, aggression, diarrhea, feeling tired, and muscle cramps. [8] [11] Serious side effects may include abnormal heart rhythms, urinary incontinence, and ...
Memantine/donepezil, sold under the brand name Namzaric among others, is a fixed dose combination medication used for the treatment of dementia of the Alzheimer's type. [1] It contains memantine , as the hydrochloride, a NMDA receptor antagonist ; and donepezil as the hydrochloride, an acetylcholinesterase inhibitor . [ 1 ]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The Merck Manual of Geriatrics was introduced in 1990, focusing on health care for older patients. The Merck Manual of Health & Aging is a consumer edition. The Manuals for human health were converted to a web-based format in 2015 and are hosted on MerckManuals.com in the US and Canada, and MSDManuals.com throughout the rest of the world.
European Union privacy watchdogs hit Facebook owner Meta with fines totaling 251 million euros on Monday after an investigation into a 2018 data breach on the social media platform that exposed ...
Related: 15 Fun Games Like Connections to Play Every Day. Show comments. Advertisement. Advertisement. Holiday Shopping Guides. See all. AOL. The best air purifiers of 2025. AOL.
On Tuesday, a San Francisco jury found Nima Momeni guilty for the killing of Cash App founder Bob Lee back in April 2023.